Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A planned study will compare the transdermal absorption of oxymorphone from application of the patch to different parts of the body

Trial Profile

A planned study will compare the transdermal absorption of oxymorphone from application of the patch to different parts of the body

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 14 Aug 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Oxymorphone (Primary)
  • Indications Pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 14 Aug 2014 New trial record
    • 11 Aug 2014 According to a Phosphagenics media release issued in August 2014, this study will be initiated shortly. That study will inform the selection of appropriate sites for application of patches during Phase 2.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top